Embargoes

Authors

  • Glenorchy Campbell Managing Director, British Medical Journal North America
  • Gregg Gordon President, Social Science Research Network
  • Laura Helmuth Incoming President, National Association of Science Writers
  • Danny Kingsley Head of Scholarly Communication, Cambridge University
  • Eric Massant Senior Director of Government and Industry Affairs, RELX Group
  • Audrey McCulloch Chief Executive, Association of Learned and Professional Society Publishers
  • Gail McMillan Director of Scholarly Communication, Virginia Tech
  • Tony Peatfield Director of Corporate Affairs, Medical Research Council, Research Councils UK
  • Ann Riley President, Association of College and Research Libraries
  • Will Schweitzer Director of Product Development, AAAS/Science
  • Keith Webster Dean of Libraries, Carnegie Mellon University

DOI:

https://doi.org/10.13021/G8CC8V

Abstract

In an information system where so much information is destined for subscription journals, the assumption has been that embargoes allow publishers time to recoup their investments, and also allow the press time to prepare news articles about research. Is this assumption warranted? Why or why not? Is the public interest being served by embargoes? What about by embargoes on federally-funded research? Are there any facts or options that havenââ¬â¢t yet been considered to address the concerns animating the embargo solution?

Downloads

Published

2016-04-22

Issue

Section

Questions